Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-18-071741)

Filing Details

Accession Number:: 0001104659-18-071741
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-12-06 17:34:26
Reporting Period:: 2018-12-04

Accepted Time:: 2018-12-06 17:34:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1720893	Bioxcel Therapeutics Inc.	BTAI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1256126	Peter Mueller	C/O Bioxcel Therapeutics, Inc. 555 Long Wharf Drive Branford CT 06511		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-12-04	1,076	$5.09	146,594	No	4	P	Direct
Common Stock	Acquisiton	2018-12-04	325	$5.11	146,919	No	4	P	Direct
Common Stock	Acquisiton	2018-12-04	344	$5.12	147,263	No	4	P	Direct
Common Stock	Acquisiton	2018-12-04	200	$5.13	147,463	No	4	P	Direct
Common Stock	Acquisiton	2018-12-04	2,062	$5.15	149,525	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct